FHIR interoperability Africa work has moved beyond technical discussion. Countries are digitizing records, claims, laboratories, supply chains, and public-health reporting, but many systems still cannot exchange patient-level data safely or consistently. HL7 FHIR gives implementers a modern standard for APIs and data resources. It does not, by itself, solve governance, terminology, identity, workflow, or data-quality problems.
That distinction matters. Africa does not need more isolated platforms. It needs health data interoperability that lets systems exchange the right data, with the right consent and safeguards, at the point where care or research decisions are made.
What FHIR interoperability Africa work is trying to solve
FHIR stands for Fast Healthcare Interoperability Resources. It is an HL7 standard that represents clinical and administrative data as modular resources such as Patient, Observation, Encounter, MedicationRequest, DiagnosticReport, Condition, and Practitioner. These resources can be exchanged through web APIs in formats familiar to modern software teams.
FHIR matters because many older health-data interfaces were difficult to implement, expensive to maintain, and poorly suited to mobile or cloud-first systems. FHIR makes it easier for an application to request a medication list, submit a lab result, retrieve a patient summary, or connect a decision-support tool to a clinical record.
For African health systems, the value is concrete. Many countries already run a mix of DHIS2, OpenMRS, custom ministry systems, commercial hospital systems, laboratory platforms, and mobile community-health tools. FHIR can act as connective tissue if each system maps data in a consistent way.
The urgent problem is continuity, not elegance. Patients move between community health workers, clinics, district hospitals, referral hospitals, laboratories, pharmacies, and insurers. If each system stores a different fragment, clinicians repeat tests, patients retell histories, and ministries see delayed or incomplete information. FHIR matters when it reduces that friction.
The current state of HL7 Africa adoption
HL7 Africa adoption is uneven. Some markets, including Kenya, Rwanda, Nigeria, Ghana, South Africa, and parts of North Africa, appear to have more visible digital-health and interoperability activity. Many other countries are still focused on digitizing core workflows before advanced interoperability becomes realistic.
Open-source ecosystems are important. OpenMRS has FHIR modules and a long history in African HIV, tuberculosis, and primary-care programmes. DHIS2 is widely deployed as an HMIS platform for aggregate reporting, and DHIS2 Tracker/Event programs support individual-level and case-based workflows that can be integrated with EMRs and other systems. OpenHIE provides architecture patterns used by implementers in several low- and middle-income country health information exchange projects.
WHO's SMART Guidelines provide standards-based, reusable digital health components and implementation guidance that countries can adapt for digital systems. Countries can choose different software while still reusing guideline content, data elements, terminology, and exchange patterns.
Where OpenMRS FHIR fits
OpenMRS FHIR is one of the most relevant entry points because OpenMRS is already deeply embedded in African EMR infrastructure. As described in electronic health records in Africa, KenyaEMR, UgandaEMR, and several other implementations grew from OpenMRS foundations.
The OpenMRS FHIR2 module supports FHIR APIs for resources including Patient, Encounter, Observation, and MedicationRequest, with implementation details depending on module version and local configuration. That can help connect EMRs to analytics platforms, lab systems, patient apps, referral tools, and research repositories.
The limitation is that a FHIR endpoint is only as good as the data behind it. If facilities use inconsistent diagnosis concepts, missing identifiers, local free-text fields, or incomplete encounter records, the API will expose inconsistency faster. Interoperability projects therefore need terminology mapping, data-quality review, and implementation guides, not just software installation.
Interoperability use cases that matter
Judge health data interoperability by whether it improves care, reporting, operations, or research.
The first high-value use case is referrals. A patient moving from a primary clinic to a district hospital should not lose diagnosis history, medication records, allergies, lab results, or pregnancy status. FHIR can support referral summaries and continuity-of-care documents if facilities can identify the same patient.
The second use case is laboratory integration. Lab systems often sit apart from EMRs. Structured exchange of orders and results reduces delays, transcription errors, and lost results.
The third use case is insurance and claims. As countries expand health insurance or strategic purchasing, claims systems need reliable encounter, diagnosis, procedure, and medication data. Interoperability reduces duplicate entry and improves auditability.
The fourth use case is research-ready data. De-identified longitudinal records become more useful when they are mapped to common resources and terminologies. Kapsule's data work depends on this principle: usable research data is created through standardization and governance, not extraction alone.
Patient identity is the hardest dependency
FHIR can move data, but it cannot decide whether two records belong to the same person. Patient identity remains one of the hardest interoperability challenges in Africa.
Some countries have national IDs, but coverage may be incomplete, especially for children, migrants, refugees, and rural populations. Facility-level identifiers often differ across hospitals. Names may be spelled differently across languages and systems. Dates of birth may be estimated.
Master patient index services can help, but they require policy decisions. What identifiers are allowed? Who can match records? What error rate is acceptable? How are duplicate records resolved? How does consent work when data moves between providers?
Without identity strategy, FHIR projects can produce technically valid exchanges that create safety risks.
Implementation guide before implementation
Good FHIR projects start with an implementation guide. This document defines which resources are used, which fields are mandatory, which terminology systems apply, which profiles constrain the data, and how authentication works.
For example, a national maternal-health exchange might define how pregnancy status, antenatal visits, HIV testing, syphilis screening, ultrasound results, danger signs, referrals, and delivery outcomes are represented. A lab exchange might define how orders, specimens, results, reference ranges, and abnormal flags are handled.
Implementation guides prevent each vendor from interpreting FHIR differently. They also give ministries, donors, and implementers a shared contract for procurement and evaluation.
Testing belongs in the guide from day one. A national or programme-level implementation should include sample payloads, validation tools, conformance tests, and reference servers. Otherwise, every vendor can claim to be "FHIR compliant" while exchanging data that cannot be used by another system.
Procurement language needs the same specificity. Contracts should require named FHIR profiles, terminology bindings, export capabilities, and documentation. They should also require vendors to support data portability at the end of a contract, so the health system is not locked into a single platform.
Governance, privacy, and trust
Interoperability increases the value of health data and the risk of misuse. Countries need rules for access control, audit logs, consent, de-identification, and cross-border transfer. This is especially important when systems connect public facilities, private hospitals, insurers, donors, and research partners.
Technical teams cannot make those decisions alone. Ministries of health, data protection authorities, ethics committees, professional councils, patient representatives, and implementers all need a voice.
The trust question is simple: patients and clinicians need to know that data exchange will improve care or legitimate research without exposing people to harm. Interoperability without trust will stall.
Security architecture also needs attention. API-based exchange requires authentication, authorization, encryption, audit logging, and incident response. In low-resource settings, weak operational security can undo strong technical design. A health information exchange needs to know who accessed which data, for what purpose, and under what authority.
Privacy rules must be translated into workflow. If a patient refuses a particular data use, the system needs a way to record and enforce that preference. If research access is approved only for de-identified data, the platform needs a de-identification process that is separate from routine clinical exchange.
Why this matters for research
Interoperability is often discussed as a care-delivery issue, but it also shapes evidence generation. Research datasets become more reliable when data elements are consistent across facilities and countries. A blood pressure result, HIV viral load, cancer diagnosis, or medication exposure should not need to be reinterpreted from scratch in every database.
FHIR can support research by making extraction more predictable and by preserving context around encounters, observations, and medications. It cannot remove the need for protocol-specific curation, but it can reduce the cost of getting to an analyzable dataset. That makes it a working foundation for health data aggregation across facilities and countries.
For African research networks, this matters. Shared standards can let institutions collaborate without giving up local control of their systems or data.
Practical takeaways
FHIR gives teams a standard, but the hard work remains. African health systems can use it where there is a clear exchange need, a governance model, a terminology strategy, and an implementation guide. Donors and vendors should fund the unglamorous work: mapping, testing, documentation, training, and data-quality improvement.
The next phase of FHIR interoperability in Africa will be judged by live use cases: referrals completed, lab results returned, claims processed, records linked, and datasets made research-ready under appropriate safeguards.
Kapsule provides access to structured, de-identified health records covering over 75 million patients across 14 African countries. Contact our team to discuss how interoperable health data can support research, market intelligence, and evidence generation.
This article is intended for informational purposes only and does not constitute legal, medical, or regulatory advice. Readers should obtain independent professional counsel for their specific circumstances.